Jerry Jaboin to Retrospective Studies
This is a "connection" page, showing publications Jerry Jaboin has written about Retrospective Studies.
Connection Strength
0.570
-
Application of tumor treating fields for newly diagnosed glioblastoma: understanding of nationwide practice patterns. J Neurooncol. 2018 Oct; 140(1):155-158.
Score: 0.094
-
Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma. Neuro Oncol. 2017 Sep 01; 19(9):1263-1270.
Score: 0.089
-
Treatment of the ventral intermediate nucleus for medically refractory tremor: A cost-analysis of stereotactic radiosurgery versus deep brain stimulation. Radiother Oncol. 2017 10; 125(1):136-139.
Score: 0.088
-
A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas. Radiat Oncol. 2014 Jan 27; 9:38.
Score: 0.069
-
Survival following gamma knife radiosurgery for brain metastasis from breast cancer. Radiat Oncol. 2013 May 29; 8:131.
Score: 0.066
-
Academic patterns of practice regarding CT simulation scans and radiology?review. J Med Imaging Radiat Sci. 2022 12; 53(4):659-663.
Score: 0.032
-
Geriatric patient outcomes in a multidisciplinary central nervous system community hospital clinic for radiation oncology and neurosurgery (RADIANS). J Geriatr Oncol. 2022 06; 13(5):648-653.
Score: 0.030
-
National trends in management of adult myxopapillary ependymomas. J Clin Neurosci. 2020 Mar; 73:162-167.
Score: 0.026
-
Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression. Neuro Oncol. 2019 03 18; 21(4):517-526.
Score: 0.025
-
Concurrent Radiosurgery and Immune Checkpoint Inhibition: Improving Regional Intracranial Control for Patients With Metastatic Melanoma. Am J Clin Oncol. 2019 03; 42(3):253-257.
Score: 0.025
-
Increase in mastectomies performed in patients in the community setting undergoing MRI. Breast J. 2011 May-Jun; 17(3):256-9.
Score: 0.014
-
Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Jun 01; 77(2):468-76.
Score: 0.013